PDE-5 inhibitors
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Treatment of erectile dysfunction (ED)
- Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening (Revatio and Adcirca)
- Treatment of benign prostatic hyperplasia (Cialis)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Treatment of erectile dysfunction (ED)
- Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening (Revatio and Adcirca)
- Treatment of benign prostatic hyperplasia (Cialis)
There's more to see -- the rest of this entry is available only to subscribers.